EA200100819A1 - Способ получения мембранных пузырьков - Google Patents

Способ получения мембранных пузырьков

Info

Publication number
EA200100819A1
EA200100819A1 EA200100819A EA200100819A EA200100819A1 EA 200100819 A1 EA200100819 A1 EA 200100819A1 EA 200100819 A EA200100819 A EA 200100819A EA 200100819 A EA200100819 A EA 200100819A EA 200100819 A1 EA200100819 A1 EA 200100819A1
Authority
EA
Eurasian Patent Office
Prior art keywords
obtaining membrane
bubbles
membrane bubbles
obtaining
vesicles
Prior art date
Application number
EA200100819A
Other languages
English (en)
Other versions
EA003235B1 (ru
Inventor
Оливье Деллэн
Себастьян Амигорена
Филипп Рамо
Жоэль Крузе
Original Assignee
ЭйПи СЕЛЛС ИНК.
Энститю Насьональ Де Ля Санте Э Де Ля Решерш Медикаль
Энститю Кюри
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ЭйПи СЕЛЛС ИНК., Энститю Насьональ Де Ля Санте Э Де Ля Решерш Медикаль, Энститю Кюри filed Critical ЭйПи СЕЛЛС ИНК.
Publication of EA200100819A1 publication Critical patent/EA200100819A1/ru
Publication of EA003235B1 publication Critical patent/EA003235B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34—Size selective separation, e.g. size exclusion chromatography, gel filtration, permeation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/20—Anion exchangers for chromatographic processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Способ получения мембранных пузырьков из биологического образца характеризуется тем, что он содержит, по меньшей мере, одну стадию обработки образца путем анионообменной и/или гельпроникающей хроматографии. Изобретение используют для получения пузырьков различного происхождения и различной природы, в частности из антигенпредставляющих клеток или опухолевых клеток. Изобретение относится также к таким образом полученным пузырькам и их применениям.Отчет о международном поиске был опубликован 2000.11.16.
EA200100819A 1999-01-27 2000-01-19 Способ получения мембранных пузырьков EA003235B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9900886A FR2788780B1 (fr) 1999-01-27 1999-01-27 Procede de preparation de vesicules membranaires
PCT/FR2000/000105 WO2000044389A2 (fr) 1999-01-27 2000-01-19 Procede de preparation de vesicules membranaires

Publications (2)

Publication Number Publication Date
EA200100819A1 true EA200100819A1 (ru) 2001-12-24
EA003235B1 EA003235B1 (ru) 2003-02-27

Family

ID=9541269

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100819A EA003235B1 (ru) 1999-01-27 2000-01-19 Способ получения мембранных пузырьков

Country Status (11)

Country Link
US (1) US6899863B1 (ru)
EP (1) EP1143982A2 (ru)
JP (1) JP2002535665A (ru)
CN (1) CN1355704A (ru)
AU (1) AU768322B2 (ru)
CA (1) CA2360752A1 (ru)
EA (1) EA003235B1 (ru)
FR (1) FR2788780B1 (ru)
HK (1) HK1042647A1 (ru)
IL (1) IL143692A0 (ru)
WO (1) WO2000044389A2 (ru)

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2454756C (en) 2001-08-17 2014-02-18 Anosys, Inc. Methods and compounds for the targeting of protein to exosomes
EP1766053A4 (en) * 2004-06-02 2007-12-12 Sourcepharm Inc MICROVESICLES CONTAINING RNA AND METHODS
US8021847B2 (en) 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
WO2007127848A1 (en) * 2006-04-26 2007-11-08 University Of Louisville Research Foundation, Inc Isolation of membrane vesicles from biological fluids and methods of using same
CN101641010A (zh) * 2007-01-26 2010-02-03 路易斯维尔大学研究基金会公司 用作疫苗的外来体组分的修饰
US20100255514A1 (en) * 2007-08-16 2010-10-07 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
JP5769417B2 (ja) 2007-08-16 2015-08-26 ザ ロイヤル インスティチューション フォー ザ アドバンスメント オブ ラーニング／マギル ユニバーシティ 腫瘍細胞由来微小胞
ES2936256T3 (es) * 2008-02-01 2023-03-15 Massachusetts Gen Hospital Uso de microvesículas en el diagnóstico, y pronóstico de enfermedades y afecciones médicas
US20220162704A1 (en) * 2008-02-01 2022-05-26 The General Hospital Corporation Methods of preparing microvesicle micrornas from bodily fluids
US11266736B2 (en) 2008-04-17 2022-03-08 Vin De Bona Trading Company Pte Ltd Method of painting micro vesicles
JP2012507300A (ja) 2008-10-30 2012-03-29 カリス ライフ サイエンシズ ルクセンブルク ホールディングス Ｒｎａパターンを評価する方法
CN107254538A (zh) * 2008-11-12 2017-10-17 卡里斯生命科学瑞士控股有限责任公司 使用外来体来确定表现型的方法和系统
KR20120037992A (ko) 2009-07-16 2012-04-20 더 제너럴 하스피탈 코포레이션 핵산 분석
EP3865590B1 (en) 2009-09-09 2024-04-10 The General Hospital Corporation Use of microvesicles in analyzing kras mutations
EP3461912B1 (en) 2009-09-09 2022-07-13 The General Hospital Corporation Use of microvesicles in analyzing nucleic acid profiles
WO2011053257A2 (en) 2009-11-02 2011-05-05 Agency For Science, Technology And Research (A*Star) Methods of monitoring cellular states
CA2782284A1 (en) 2009-11-30 2011-06-03 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Methods and systems for isolating, storing, and analyzing vesicles
US20120315324A1 (en) * 2010-02-05 2012-12-13 University Of Louisville Research Foundation, Inc. Exosomal compositions and methods for the treatment of disease
JP5808349B2 (ja) 2010-03-01 2015-11-10 カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー セラノーシスのためのバイオマーカー
CA2795776A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers for disease
EP2591359B1 (en) 2010-07-07 2017-03-01 Aethlon Medical Inc Methods for quantifying exosomes
US20140045915A1 (en) 2010-08-31 2014-02-13 The General Hospital Corporation Cancer-related biological materials in microvesicles
WO2012064993A1 (en) 2010-11-10 2012-05-18 Exosome Diagnosties, Inc. Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom
SG190450A1 (en) * 2010-12-20 2013-06-28 Agency Science Tech & Res Method of purifying exosomes
ES2744589T3 (es) 2011-05-11 2020-02-25 Exosome Diagnostics Inc Extracción de ácido nucleico de materiales biológicos heterogéneos
WO2012177906A1 (en) 2011-06-21 2012-12-27 Alnylam Pharmaceuticals, Inc. Assays and methods for determining activity of a therapeutic agent in a subject
GB201110783D0 (en) 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
GB201110777D0 (en) 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
ES2395793B1 (es) * 2011-07-28 2013-12-27 Consejo Superior De Investigaciones Científicas (Csic) Procedimiento de obtención y usos de vesículas de membrana de un organismo marino para su utilización industrial.
EP2748335B1 (en) 2011-08-22 2018-10-03 Exosome Diagnostics, Inc. Urine biomarkers
US10174361B2 (en) 2011-11-10 2019-01-08 Exosome Diagnostics, Inc. Cerebrospinal fluid assay
JP2015500013A (ja) 2011-11-30 2015-01-05 ユニバーシティ オブ ブレーメン 胎盤組織におけるｍｉＲＮＡの発現
CN103479682B (zh) * 2012-06-14 2015-03-11 苏州恒宇生物科技有限公司 一种植物来源活性成分-纳米级膜性囊泡的制备方法
CA2879322A1 (en) * 2012-07-19 2014-01-23 Reneuron Limited Stem cell microparticles
CA2879337C (en) * 2012-07-19 2021-11-30 Atlantic Cancer Research Institute Method for the isolation of microvesicles
EP2885414B1 (en) 2012-08-15 2020-09-23 The University of Chicago Exosome-based therapeutics against neurodegenerative disorders
CN104995311A (zh) 2012-08-30 2015-10-21 外来体诊断公司 用于核酸测定的对照
EP2903597B1 (en) 2012-10-03 2019-12-18 Exosome Diagnostics Inc. Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions
DK2906717T3 (en) 2012-10-11 2019-04-01 Vin De Bona Trading Company Pte Ltd PROCEDURE FOR PAINTING MICROVESICS
US10942184B2 (en) 2012-10-23 2021-03-09 Caris Science, Inc. Aptamers and uses thereof
JP6449781B2 (ja) 2013-01-03 2019-01-09 エクソサム ダイアグノスティクス，インコーポレイティド 微細小胞の単離方法
US11513125B2 (en) 2013-03-14 2022-11-29 Pioma, Inc. Microvesicle histone H2AX as a biomarker for genotoxic stress
US11274139B2 (en) 2013-04-12 2022-03-15 Evox Therapeutics Ltd Therapeutic delivery vesicles
EP3495509B1 (en) 2013-08-06 2021-12-15 Exosome Diagnostics, Inc. Urine biomarker cohorts, gene expression signatures, and methods of use thereof
GB201317887D0 (en) 2013-10-09 2013-11-20 Reneuron Ltd Product
CN105980615A (zh) 2013-08-28 2016-09-28 卡里斯生命科学瑞士控股有限公司 寡核苷酸探针及其用途
WO2015048844A1 (en) * 2013-10-02 2015-04-09 Xosoma Pty Ltd A method of producing exosomes
EP3061807B1 (en) 2013-10-25 2019-03-06 Toppan Printing Co., Ltd. Membrane vesicle recovery device, membrane vesicle recovery method, and membrane vesicle analysis method
FR3014198B1 (fr) * 2013-12-03 2017-03-03 Biomerieux Sa Procede d'isolement d'exosomes
JP6343671B2 (ja) * 2013-12-12 2018-06-13 サムスン ライフ パブリック ウェルフェア ファウンデーション トロンビンを利用した幹細胞由来のエキソソームの生成促進方法
KR101661847B1 (ko) 2014-03-18 2016-09-30 사회복지법인 삼성생명공익재단 줄기세포 유래 엑소좀을 유효성분으로 포함하는 뇌 염증성 질환의 치료용 조성물
US10844436B2 (en) 2014-04-01 2020-11-24 Cornell University Use of double-stranded DNA in exosomes: a novel biomarker in cancer detection
US11268085B2 (en) 2014-05-27 2022-03-08 Exosome Diagnostics, Inc. Methods for isolating microvesicles and extracting nucleic acids from biological samples
CN107002075B (zh) * 2014-07-09 2021-07-30 外来体诊断公司 从生物样品中分离微泡和提取核酸的方法
WO2016011383A1 (en) 2014-07-17 2016-01-21 The Trustees Of The University Of Pennsylvania Methods for using exosomes to monitor transplanted organ status
EP3173143A4 (en) 2014-07-24 2018-06-27 Toppan Printing Co., Ltd. Lipid membrane structure, lipid-membrane-structure-immobilization carrier, and method for fusing cells
EP3112474A1 (en) 2015-06-29 2017-01-04 Evonik Degussa GmbH Method of detecting avian necrotic enteritis
WO2016145128A1 (en) 2015-03-09 2016-09-15 Caris Science, Inc. Oligonucleotide probes and uses thereof
ES2941757T3 (es) * 2015-06-12 2023-05-25 Hudson Inst Med Res Exosomas amnióticos alogénicos de mamífero para el tratamiento de una enfermedad fibrótica
CA2991045A1 (en) 2015-06-29 2017-01-05 Caris Science, Inc. Therapeutic oligonucleotides binding c1q
EP3328873A4 (en) 2015-07-28 2019-04-10 Caris Science, Inc. TARGETED OLIGONUCLEOTIDES
EP3165926A1 (en) 2015-11-06 2017-05-10 Humanitas Mirasole S.p.A. Method for characterization of cell specific microvesicles
CN106811428A (zh) * 2015-11-30 2017-06-09 复旦大学 一种提取细菌外排膜囊泡的方法
RU2608509C1 (ru) * 2016-02-11 2017-01-18 Елена Сергеевна Кастарнова Способ получения экзосом из крови
CN109069599A (zh) 2016-03-03 2018-12-21 法国古士塔柏罗斯学院 针对癌症的基于ptp的疫苗
WO2017181161A1 (en) 2016-04-15 2017-10-19 Predicine, Inc. Systems and methods for detecting genetic alterations
WO2017181183A1 (en) 2016-04-15 2017-10-19 Exosome Diagnostics, Inc. Plasma-based detection of anaplastic lymphoma kinase (alk) nucleic acids and alk fusion transcripts and uses thereof in diagnosis and treatment of cancer
EP3452613B1 (en) 2016-05-05 2021-12-29 Exosome Diagnostics, Inc. Profiling microvesicle nucleic acids and uses thereof as signatures in diagnosis of renal transplant rejection
EP3455355B1 (en) 2016-05-13 2022-04-13 Exosome Diagnostics, Inc. Automated and manual methods for isolation of extracellular vesicles and co-isolation of cell-free dna from biofluids
US10955410B2 (en) 2016-05-24 2021-03-23 Japanese Foundation For Cancer Research Method of recovering extracellular vesicles and container for extracellular vesicles
US11299733B2 (en) 2016-07-15 2022-04-12 University Of Massachusetts Process of delivering small RNAs to sperm
IL247368A0 (en) 2016-08-18 2016-11-30 Yeda Res & Dev Diagnostic and therapeutic uses of exosomes
US11174503B2 (en) 2016-09-21 2021-11-16 Predicine, Inc. Systems and methods for combined detection of genetic alterations
WO2018076018A1 (en) 2016-10-21 2018-04-26 Exosome Diagnostics, Inc. Sequencing and analysis of exosome associated nucleic acids
AU2017366813B2 (en) 2016-11-30 2023-04-20 Exosome Diagnostics, Inc. Methods and compositions to detect mutations in plasma using exosomal RNA and cell free DNA from non-small cell lung cancer patients
CN110072994A (zh) * 2016-12-23 2019-07-30 埃克波菲尔有限公司 用于纯化或分离微泡和外泌体的方法与组合物
WO2018126278A2 (en) 2017-01-02 2018-07-05 Exosome Diagnostics, Inc. Methods to distinguish rna and dna in a combined preparation
KR101875594B1 (ko) * 2017-01-13 2018-07-06 ㈜로제타엑소좀 금속을 이용한 세포밖 소포체의 분리 방법
PL3622082T3 (pl) 2017-05-12 2023-07-31 Evonik Operations Gmbh Sposób wykrywania chorób wywołanych przez C. perfringens w stadzie ptaków
US11891664B2 (en) 2017-05-17 2024-02-06 Exosome Diagnostics, Inc. Methods of detecting renal transplant rejection using microvesicle nucleic acid biomarkers
CN111133106A (zh) 2017-07-12 2020-05-08 外来体诊断公司 用于分离和富集生物流体来源的细胞外囊泡的方法及其使用方法
US11345957B2 (en) 2017-07-18 2022-05-31 Exosome Diagnostics, Inc. Methods of treating glioblastoma in a subject informed by exosomal RNA signatures
KR102107844B1 (ko) * 2017-07-26 2020-05-07 ㈜로제타엑소좀 양이온을 이용한 세포밖 소포체의 분리 방법
TR201716062A2 (tr) * 2017-10-18 2019-05-21 Tuerkiye Bilimsel Ve Teknolojik Arastirma Kurumu Tuebitak Bi̇r eksozomal terapöti̇k taşiyici üreti̇m yöntemi̇ ve bu yönteme uygun bi̇r şeki̇lde elde edi̇len bi̇r eksozomal terapöti̇k taşiyici
GB201717446D0 (en) 2017-10-24 2017-12-06 Evox Therapeutics Ltd Affinity purification of engineering extracellular vesicles
US20200339987A1 (en) 2017-11-09 2020-10-29 Alnylam Pharmaceuticals, Inc. Assays and methods for determining expression of the lect2 gene
US10729156B2 (en) 2017-11-21 2020-08-04 Purina Animal Nutrition Llc Methods of purifying exosomes
CN112136044B (zh) 2018-02-15 2024-05-28 耶迪特普大学 通过两相流体系统的外来体分离方法
CN111770931B (zh) * 2018-02-20 2023-08-25 高丽大学校产学协力团 用于分离外泌体的多柱及外泌体分离方法
EP3802884A1 (en) 2018-06-06 2021-04-14 Exosome Diagnostics, Inc. Methods for developing urine biomarkers and for detecting bladder cancer
GB201809622D0 (en) 2018-06-12 2018-07-25 Evox Therapeutics Ltd Engineering extracellular vesicles for affinity purification
CN108841777A (zh) * 2018-06-22 2018-11-20 北京恩泽康泰生物科技有限公司 基于静电吸附的胞外囊泡及其内含物的提取方法及装置
JP7315243B2 (ja) * 2018-07-31 2023-07-26 国立大学法人三重大学 エクソソームの製造方法
US20210403881A1 (en) 2018-11-20 2021-12-30 Exosome Diagnostics, Inc. Compositions and methods for internal controls of microvesicle isolations
IT201800021226A1 (it) 2018-12-27 2020-06-27 Supsi Scuola Univ Professionale Della Svizzera Italiana Processo e dispositivo per produrre esosomi
CN109856259A (zh) * 2018-12-29 2019-06-07 南通大学附属医院 一种血清胰腺癌外泌体特异蛋白及其再验证过程
KR102212465B1 (ko) * 2019-01-16 2021-02-03 서울시립대학교 산학협력단 알엔에이 나노입자 전달을 통한 소포체의 제조방법 및 이로부터 제조된 소포체
CN109825472A (zh) * 2019-03-01 2019-05-31 易春 一种细胞外囊泡的提取方法及试剂盒
JP7513869B2 (ja) 2020-03-23 2024-07-10 澁谷工業株式会社 エクソソーム抽出装置およびエクソソームの抽出方法
WO2021209995A1 (en) 2020-04-13 2021-10-21 Exoprother Medical Ltd. Cell-derived vesicles comprising wild-type p53 protein for antiviral therapy
US20210322483A1 (en) 2020-04-16 2021-10-21 Ichilov Tech Ltd. Cell-derived particles presenting heterologous cd24 and use thereof in therapy
GB202010278D0 (en) 2020-07-03 2020-08-19 Evox Therapeutics Ltd Extracellular vesicles with improved half-life
IL277743A (en) 2020-10-01 2022-04-01 Yeda Res & Dev A method for diagnosing breast cancer
WO2022146083A1 (ko) * 2020-12-30 2022-07-07 한국과학기술원 엑소좀 분리용 조성물 및 이를 이용한 엑소좀 분리 방법
GB202105925D0 (en) 2021-04-26 2021-06-09 Evox Therapeutics Ltd Modified extracellular vesicles (EVs) with improved half-life
JP2023104650A (ja) * 2022-01-18 2023-07-28 ダイセン・メンブレン・システムズ株式会社 細胞外小胞の分離精製方法
WO2024024336A1 (ja) * 2022-07-28 2024-02-01 株式会社ダイセル 微小有用物質を含む液の精製濃縮装置及びそれを用いた微小有用物質の精製濃縮液の製造方法
CN117070450B (zh) * 2023-10-12 2024-01-16 哈药集团生物工程有限公司 一种外泌体的纯化方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3852037T2 (de) * 1987-07-29 1995-03-23 Liposome Co Inc Verfahren zur trennung von teilchen nach grösse.
ATE319477T1 (de) * 1995-08-03 2006-03-15 Univ Leiden Antigen presentierende bläschen, die von zellen ableiten
US6165785A (en) * 1996-05-24 2000-12-26 University Of Cincinnati Bone marrow cultures for developing suppressor and stimulator cells for research and therapeutic applications
AU2710897A (en) * 1996-05-31 1998-01-05 Whitaker Corporation, The Rechargeable battery connector
FR2766205B1 (fr) * 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede

Also Published As

Publication number Publication date
WO2000044389A3 (fr) 2000-11-16
EA003235B1 (ru) 2003-02-27
JP2002535665A (ja) 2002-10-22
WO2000044389A2 (fr) 2000-08-03
EP1143982A2 (fr) 2001-10-17
FR2788780A1 (fr) 2000-07-28
CA2360752A1 (fr) 2000-08-03
IL143692A0 (en) 2002-04-21
AU3056100A (en) 2000-08-18
HK1042647A1 (zh) 2002-08-23
AU768322B2 (en) 2003-12-11
FR2788780B1 (fr) 2001-03-30
US6899863B1 (en) 2005-05-31
CN1355704A (zh) 2002-06-26

Similar Documents

Publication Publication Date Title
EA200100819A1 (ru) Способ получения мембранных пузырьков
ATE481480T1 (de) Methoden und zusammensetzungen zur herstellung von polypeptiden
NL300307I1 (nl) Werkwijzen voor de replicatie van influenzavirussen in celkweek en de influenzavirussen die verkrijgbaar zijn met behulp van de werkwijze
DE69029657D1 (de) Menschliches cytokin, interleukin-9
DE69840448D1 (de) 13c,15n,2h markierte proteine zur nmr strukturbestimmung und deren herstellung
ATE21173T1 (de) Methode zur fluoreszenz-spektroskopischen bestimmung von biologisch aktiven substanzen.
CY1111006T1 (el) Εκριμματαση ασθενειας alzheimer
ES2132046T3 (es) Sintasas isoprenoides quimericas y usos de las mismas.
DE69638077D1 (de) Bakterielle Produktion von Interferon-beta Polypeptiden
ATE403671T1 (de) Methoden zur aufreinigung von rekombinatem humanem erythropoietin aus zellkulturüberständen
ATE307649T1 (de) Kontinuierliches verfahren zur trennung von stoffen nach molekülgrösse
NO20030495L (no) Peptider som presenteres av celler
ATE302413T1 (de) Schnelle bestimmung des verhältnisses von biologischen molekülen
ES2108654B1 (es) Procedimiento para la sintesis electroquimica de n-acetilcisteina a partir de cistina.
ATE263239T1 (de) Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)
ES2171913T3 (es) Procedimiento de puesta en evidencia de contaminantes microbiologicos vivos en una muestra de producto de uso alimentario.
DE50208262D1 (de) Verfahren zur bestimmung von flüchtigen substanzen in lösung
DE59505393D1 (de) Verfahren zur gewinnung von zellstoff
DE69816871D1 (de) Verwendung von oxidationsfördernden chemikalien für die oxidation von einem polymer, das die alkoholkonfiguration eines oxidierbaren galaktosetyps enthält.
DK0536252T3 (da) Phosphortrilactamer og fremgangsmåde til deres fremstilling
TR200101157T2 (tr) Bitkiden elde edilen antiparazit ve antimantar bileşikleri ve bileşikleri çıkartma yöntemleri.
DK438883D0 (da) 1,2,3,4-tetrahydro-1-aminomethyl-4-phenyl-isoquinoliner, samt fremgangsmade til fremstilling heraf
KIRIHARA et al. Distinction of the species of mushrooms by capillary electrophoresis
FR2668036B1 (fr) Procede de tannage des substances proteiques, notamment des substances proteique vegetales telles que les proteines d'oleagineux et substances proteiques tannees obtenues par ce procede.
WO2001006226A3 (de) Verfahren zur bestimmung der proliferationsaktivität von zellen

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU